Aumolertinib in EGFR-Mutant Lung Cancer: Will the Promise of Cost Disruption Ease Access? Aggarwal C, Gyawali B. J Clin Oncol 2022 Jun 9:JCO2200903. doi: 10.1200/JCO.22.00903.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Aggarwal C, Gyawali B. Aumolertinib in EGFR-Mutant Lung Cancer: Will the Promise of Cost Disruption Ease Access? J Clin Oncol 2022 Jun 9:JCO2200903. doi: 10.1200/JCO.22.00903.
PMID: 35679530